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Autosomal dominant renal Fanconi syndrome is a genetic model for the study of proximal renal tubular transport
pathology. We were able to map the locus for this disease to human chromosome 15q15.3 by genotyping a central
Wisconsin pedigree with 10 affected individuals. After a whole-genome scan with highly polymorphic simple
sequence repeat markers, a maximum LOD score of 3.01 was calculated for marker D15S659 on chromosome
15q15.3. Linkage and haplotype analysis for an additional 24 markers flanking D15S659 narrowed the interval
to ∼3 cM, with the two highest single-point LOD scores observed being 4.44 and 4.68 (for D15S182 and D15S537,
respectively). Subsequently, a complete bacterial artificial chromosome contig was constructed, from the High
Throughput Genomic Sequence Database, for the region bounded by D15S182 and D15S143. The identification
of the gene and gene product altered in autosomal dominant renal Fanconi syndrome will allow the study of the
physiology of proximal renal tubular transport.
Renal Fanconi syndrome (RFS [MIM 134600]) is a con-
sequence of decreased solute reabsorption in the prox-
imal tubule of the kidney. The proximal tubule reabsorbs
a very large percentage of the solute filtered by the glo-
merulus. This solute transfer is a very high energy pro-
cess. The clinical and laboratory manifestations of pa-
tients with RFS are thus a consequence of the failure of
solute and water reabsorption in the proximal tubule.
The patients have polydipsia and polyuria with phos-
phaturia, glycosuria, and aminoaciduria. They may de-
velop hypophosphatemic rickets or osteomalacia, aci-
dosis, and a tendency toward dehydration. Some will
eventually develop renal insufficiency. Common labo-
ratory abnormalities include glucosuria with a normal
serum glucose, hyperaminoaciduria, hypophosphate-
mia, progressive renal insufficiency, renal sodium and
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potassium wasting, acidosis, uricosuria, and low–mol-
ecular weight proteinuria.
The causes of RFS are quite numerous; they include
inborn errors of metabolism, such as cystinosis, galac-
tosemia, fructose intolerance, tyrosinemia, Wilson dis-
ease, Lowe syndrome, some of the glycogenoses, and
mitochondrial diseases such as cytochrome c oxidase
deficiency. Acquired causes include heavy-metal poison-
ing, glue sniffing, and, most commonly, toxicity from
chemotherapeutic drugs such as cisplatin and, particu-
larly, iphosphamide (Foreman 1994). Familial RFS is a
genetic model for the study of the pathophysiology of
renal tubular transport. Seven families, including the one
considered in the present study (Wen et al. 1989), have
been described as exhibiting an autosomal dominant
mode of inheritance of idiopathic RFS (Tolaymat et al.
1992); autosomal recessive (Illig and Prader 1961) and
X-linked inheritance (Niemann et al. 1968) have also
been reported. Determination of the gene defect respon-
sible for autosomal dominant RFS would provide fun-
damental insight into the physiology of normal renal
tubular transport. Such insight may lead to better treat-
ment for patients with RFS.
We herein present the results of linkage and haplotype
analysis for a large central Wisconsin pedigree with au-
tosomal dominant RFS. The diagnosis of autosomal
dominant RFS in this pedigree has been established and
Figure 1 Pedigree of family with autosomal dominant RFS, showing haplotypes constructed for 21 markers from the 15q15-15q21 region
in the second and third generations; the haplotypes of the first generation were inferred. Blackened symbols represent affected individuals,
unblackened symbols unaffected individuals, and symbols with a question mark indicate individuals whose phenotype cannot be determined
because they may be presymptomatic. The RFS haplotype is depicted by a green bar. ? p Unknown alleles.
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Table 1
Single-Point LOD Scores for 30 Markers on Chromosome 15q11.2-q24
MARKER
SINGLE-POINT LOD SCORE AT v p
Zmax vmax
a.00 .01 .05 .10 .20 .30 .40
D15S822  2.18 .29 .33 .63 .49 .17 .63 .20
D15S165  1.39 .14 .28 .49 .40 .16 .49 .21
D15S231  1.96 .66 .19 .11 .13 .05 .14 .26
D15S144  1.65 .18 .74 .91 .64 .21 .92 .17
ACTC  .75 1.86 2.08 1.87 1.29 .50 2.09 .11
D15S118 1.30 1.27 1.15 1.01 .70 .40 .12 1.30 .00
D15S102  .45 1.58 1.83 1.66 1.15 .43 1.84 .12
D15S221 1.83 1.81 1.73 1.58 1.22 .78 .29 1.83 .00
GATA50C03  .36 1.49 1.75 1.61 1.11 .42 1.77 .12
D15S194  2.32 .94 .41 .04 .03 .01 .03 .31
THBS1 2.32 2.27 2.06 1.80 1.24 .67 .18 2.32 .00
D15S1044 1.19 1.17 1.08 .97 .71 .43 .14 1.19 .00
D15S146  .75 1.86 2.08 1.87 1.29 .50 2.09 .11
D15S214 3.31 3.25 3.02 2.72 2.05 1.30 .47 3.31 .00
D15S129  2.57 2.97 2.89 2.35 1.57 .62 2.98 .06
D15S641  2.66 3.06 2.97 2.41 1.61 .64 3.06 .06
D15S514  2.01 2.44 2.41 1.96 1.30 .49 2.46 .06
D15S780  .36 .89 .96 .77 .45 .13 .96 .09
D15S182 4.44 4.36 4.06 3.67 2.81 1.84 .74 4.44 .00
D15S537 4.68 4.60 4.29 3.88 2.98 1.96 .80 4.68 .00
D15S222  1.19 1.68 1.71 1.41 .91 .31 1.72 .08
D15S172  4.82 2.18 1.17 .37 .09 .01 .00 NA
D15S659 3.31 3.25 3.02 2.72 2.05 1.30 .47 3.31 .00
D15S1028 2.41 2.36 2.19 1.95 1.44 .87 .27 2.41 .00
D15S161 3.14 3.08 2.86 2.56 1.93 1.21 .42 3.14 .00
D15S143 3.14 3.08 2.85 2.54 1.89 1.17 .40 3.14 .00
D15S527  2.74 3.14 3.04 2.47 1.66 .69 3.14 .06
D15S643  2.45 2.86 2.78 2.27 1.52 .61 2.86 .06
D15S1507  .43 1.56 1.81 1.65 1.14 .44 1.82 .12
D15S818  5.54 2.26 1.03 .14 .07 .03 .07 .31
a Maximum-likelihood estimate of v. NA p not applicable.
reported elsewhere and has excluded both acquired
causes and inherited metabolic disease causes (Wen et
al. 1989). In this previous publication, clinical data for
three pedigree members (subjects II:3, II:5, and III:4; fig.
1) were reported. In the present study, diagnosis of Fan-
coni syndrome was established or excluded by clinical
laboratory evaluation in all but two genotyped pedigree
members (two descendants of healthy individuals were
not evaluated by laboratory tests). The clinical labora-
tory values used as diagnostic criteria for RFS were a
tubular reabsorption of phosphorus (calculated as max-
imum rate of tubular absorption of phosphate/glomer-
ular filtration rate) !2.5 mg/dl (Wen et al. 1989) and
aminoaciduria and glucosuria in patients with normal
serum glucose (Foreman 1994). Subjects were consid-
ered normal if they had normal laboratory values. Most
of the affected family members developed polyuria and
loss of proximal tubular function during the 2d decade
of life and demonstrated significant renal insufficiency
by the 3d decade. By our diagnostic criteria, 10 of the
related family members whose genomes were analyzed
had RFS and 14 did not. This study was approved by
the institutional review board of Marshfield Clinic and
St. Joseph’s Hospital. Genomic DNA was isolated from
peripheral blood cells, as described byWoo et al. (1983).
Initially, a whole-genome scan was performed using
the polymorphic markers of Weber screening sets 8 and
9 (Yuan et al. 1997; Center for Medical Genetics Web
site) to genotype the DNA of 27 pedigree members. The
average spacing of these markers is reported to be one
marker every 10 cM throughout the human genome. The
sets included 12 markers for chromosome 15, which,
according to the GeneMap’99 Database, is 110 cM in
length. In nine cases the distance between markers was
in the 8–12-cM range, and in three cases the distance
between markers was !8 or 112 cM (range 4–17 cM).
Fluorescently labeled products were generated by incor-
poration of dyes into DNA fragments via PCR. The PCR
products were resolved on denaturing polyacrylamide
gels and were detected by a scanning fluorescence de-
tector (SCAFUD) (Yuan et al. 1997). Linkage analysis
was performed using the programs MLINK and ILINK
in the LINKAGE package, version 5.1 (Lathrop et al.
1984). Pairwise LOD scores were calculated under an
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Figure 2 Diagram of the BAC clone contig of the critical region for RFS. The markers in the region are shown in boldface above the
distance line for the contig. The marker positions are shown with regard to distances within the contig (0 p telomeric end of the contig) and
indicate the BAC recombinant on which each marker resides. The GenBank accession numbers for the BAC clone sequences are represented
below the BAC-clone insert symbol (blackened diamonds connected by a line), in a tiling fashion, from left to right.
autosomal dominant, completely penetrant model with
disease allele frequency .0001. Analysis of the results of
the genomewide scan yielded a maximum LOD score
(Zmax) of 3.01 at marker D15S659 on the long arm of
chromosome 15. A LOD score of 3.0 was considered
significant for the establishment of linkage.
To further narrow the region of interest, the DNA of
23 individuals in the pedigree was analyzed with 24
additional simple sequence repeat (SSR) markers flank-
ing marker D15S659 (table 1 and fig. 1). The markers
were chosen on the basis of information available from
the Web sites of the Center for Medical Genetics, The
Genome Database, and the Genetics Location Database.
These genotypes were determined using GENESCAN
(version 2.1.1) software and an ABI 377XL DNA Se-
quencer (PE Biosystems). SSR-marker primers were pur-
chased from Research Genetics or were synthesized by
MWG Biotech, and PCRs were performed for 25 cycles
as recommended by the supplier. Genomic DNA from
CEPH individuals 1331-01 and 1331-02, with known
allele sizes, was typed, as a control, with each marker.
Linkage analysis employing the data for the addition-
al 24 markers from the interval D15S165–D15S643
mapped the locus for autosomal dominant RFS to
15q15.3, with the two highest Zmax values being 4.44
and 4.68, for markers D15S182 and D15S537, re-
spectively (table 1). Genotype data for the total of 36
markers analyzed on chromosome 15 were used to form
haplotypes. Different databases and publications (Foug-
erousse et al. 1994; Broman et al. 1998; GeneMap’99;
Genetics Location Database) have suggested different or-
ders for these markers. BLAST searches of the High
Throughput Genomic Sequence Database, using the se-
quences of the 36 markers, detected bacterial artificial
chromosome (BAC) clones containing the sequence for
each of the 36 markers searched. Additional BLAST
searches employing segments of BAC insert sequences
revealed markers ACTC and D15S1232 to reside on the
same BAC insert; markers D15S1044, THBS1,
D15S146, D15S214, and D15S129 to reside on six over-
lapping BAC inserts; and marker D15S641 to be at the
TYR03 locus (Allamand et al. 1995). A complete BAC
contig, 3 Mb in length, could be constructed for the
region flanked by the markers D15S182 and D15S143
(fig. 2). In figure 2, the GenBank accession number is
provided for each of the recombinants contributing to
the minimum tiling path for the region. The recombinant
sequence depth in the 3-Mb region ranged from two- to
sixfold, allowing all fragments of the draft-quality BAC
sequences to be ordered with a high degree of confidence.
The resulting contig represents a nearly complete and
ordered sequence of the region flanked by markers
D15S182 and D15143. Construction of the contig es-
tablished the order and proximity of the seven markers
in the critical region for RFS, which was consistent with
that published by Allamand et al. (1995) for the region
between markers THBS1 and D15S143. For the re-
maining markers, we applied the order determined by
Broman et al. (1998), which is based on the analysis of
eight CEPH families.
Haplotype analysis revealed two critical recombina-
tion events (individuals II:1 and III:11; fig. 1). A recom-
bination event between markers D15S780 and D15S182
in individual III:11 establishes the centromeric bound-
ary of the region of interest, and a recombination be-
tween markers D15S143 and D15S527 in individual II:
1 establishes the telomeric boundary. These recombi-
nation events narrow the critical region to the interval
between markers D15S182 and D15S143, which Alla-
mand and Beckmann (1997) estimated as spanning 3
cM and which, by our results, was shown to represent
a physical distance of 3 Mb (fig. 2). Candidate genes
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from the region of interest are under investigation for
the presence of segregating mutations.
The isolation of the gene and gene product that are
altered in autosomal dominant RFS will allow study of
the physiology of proximal renal tubular transport,
thereby contributing to the understanding of both he-
reditary and acquired forms of RFS. Such studies should,
consequently, lead to a better treatment of these entities.
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